Myeloperoxidase, a risk indicator for cardiovascular disease

CAFC
  • US 9,575,065 B2
  • Filed: 04/22/2016
  • Issued: 02/21/2017
  • Est. Priority Date: 01/02/2001
  • Status: Expired due to Fees
First Claim
Patent Images

1. A method of detecting elevated MPO mass in a patient sample comprising:

  • a) obtaining a plasma sample from a human patient having atherosclerotic cardiovascular disease (CVD); and

    b) detecting elevated MPO mass in said plasma sample, as compared to a control MPO mass level from the general population or apparently healthy subjects, by contacting said plasma sample with anti-MPO antibodies and detecting binding between MPO in said plasma sample and said anti-MPO antibodies.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×